乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Oncology/Hematology >

Hematology

News, opinions and meeting coverage in oncology/hematology.

<乌鸦传媒>FDA Approves Rituximab Biosimilar for NHL

Indications for front line or beyond, single agent or combination

<乌鸦传媒>Deaths from Non-Obesity-Related Cancers Higher in T2D

Even in some obesity-related malignancies, high BMI was inversely tied to cancer death

<乌鸦传媒>Sickle Cell in the ED: Old Therapies, New Strategies

With treatments unchanged in decades, docs seek to improve delivery

<乌鸦传媒>Levaquin With Chemo Reduces Bacteremia in Pediatric AML/ALL

But no advantage seen among those undergoing transplant

<乌鸦传媒>FDA Warns Against Long-Term Zmax Use in Certain Cancer Patients

Heightened risk of relapse, death seen in study of stem cell transplant recipients

<乌鸦传媒>Decades Later, Mortality for Childhood Transplant Recipients Remains High

Elevated risk requires closer follow-up care

<乌鸦传媒>Second Transplant vs Donor Lymphocyte Infusion in Relapsed AML

Both options viable, benefit more clear in certain groups

<乌鸦传媒>How Did Theranos' Holmes Fool So Many Smart People?

WSJ's John Carreyrou on how disgraced entrepreneur nearly got away with it

<乌鸦传媒>FLT3-ITD Inhibitor Improves Survival in Relapsed AML

More quizartinib-treated patients went on to stem cell transplant

<乌鸦传媒>Lymphoma Risk with JAK Inhibitors for MPNs

Preexisting aberrant B-cell clone implicated

<乌鸦传媒>Ditching Chemo Appears Viable in Frontline Follicular Lymphoma

PFS 'nearly identical' at 3 years with novel immunomodulatory combination

<乌鸦传媒>Ivosidenib Induces Deep Remissions in IDH1-Mutant AML

On strength of phase I data, drug appears headed for FDA approval

<乌鸦传媒>Platelet Stimulator OK'd for Liver Disease Patients with Scheduled Procedures

Avatrombopag (Doptelet) is first drug approved for this indication

<乌鸦传媒>CBT Tops Acupuncture for Treating Insomnia in Cancer Survivors

But both methods provide alternative to sleeping pills

<乌鸦传媒>Shocker! Is Vioxx Coming Back... as an Orphan Drug?

Milton Packer wonders whether its return represents innovation or opportunism

<乌鸦传媒>Make the Diagnosis: What鈥檚 to Blame for his Rash and Paresthesia?

Case Findings: A 52-year-old man who was undergoing chemotherapy for leukemia went to the ED 5 days after receiving cytarabine. He complained of a rapid onset of erythematous lesions on his palms and soles accompanied by tingling and burning sensations. Can you diagnose the patient?

<乌鸦传媒>New Clues to CAR T-Cell Failure

Chemo effects, T cell energy sources

<乌鸦传媒>Tranexamic Acid Immediately After Vaginal Delivery Cuts Risk of PPH

Higher rates of nausea/vomiting, but not severe adverse events

<乌鸦传媒>Gladiator Blood and Liquid Gold: Good for What Ails You?

A new book by Lydia Kang, MD, reviews the most dubious cures in history

<乌鸦传媒>Mixed Results with Regimens for Older AML Patients

Positive data with venetoclax, liposomal cytarabine-daunorubicin

<乌鸦传媒>Longer PFS in Myeloma with Add-On Daratumumab

Anti-CD38 drug boosts response to VMP regimen

<乌鸦传媒>Vince DeVita鈥檚 Oncology Opus

Medicine and music share center stage in storied career

<乌鸦传媒>CAR T Cells Drive Outcomes in MM

Studies show promise for precision immunotherapy

<乌鸦传媒>ORBIT Score Pinpoints Repeat GI Bleeds with Anticoagulation

Patients rated as high risk show greater rates of rebleeding

<乌鸦传媒>MSK Cancer Alliance: Mainly About Medicine

Bi-directional relationship strengthens regional cancer care

<乌鸦传媒>Cancer Collaboration Founded by 'Bush 41' Closes Its Doors

All agree C-Change fulfilled its mission

<乌鸦传媒>Amyloidosis Treatments Miss the Heart of the Problem

Only modest improvement in end organ function

<乌鸦传媒>Bangladesh-Boston Collaborate on ASCT Center

Two dozen patients undergo successful stem cell transplant in Dhaka

<乌鸦传媒>Survival Boost With Liposomal Tx in Older AML Patients

Agent may also provide a bridge to successful transplant

<乌鸦传媒>Novel Sickle Cell Tx Shows Promise for Pain Crises

Monoclonal antibody tied to lower incidence of adverse events

<乌鸦传媒>Keeping Chemo Patients Away From Hospitals

Is 'Come Home' ready for prime time?

<乌鸦传媒>Former NCI Chief Niederhuber Shifts Gears

At age 78, still active in research and administration

<乌鸦传媒>CML Patients Still Benefit from Transplant

Also at SOHO: Ponatinib proves mettle in pretreated CML

<乌鸦传媒>MedPAC Looks at Ways to Adjust Misvalued Services

Commission debates grouping CPT codes into families

<乌鸦传媒>Hypomethylating Agents Useful in Low-Risk MDS

Objective responses in a majority of patients

<乌鸦传媒>Combo Boosts PFS in Tough-to-Treat Myeloma

Recurrent or relapsed disease susceptible to daratumumab-bortezomib-dexamethasone

<乌鸦传媒>Transplant Remains King for New Myeloma

Significant improvement in PFS versus systemic treatment

<乌鸦传媒>Opinion Makers: Jury Still Out on Gene-Guided DLBCL Therapy

Rationale for subtyping, but treatment data inconclusive

<乌鸦传媒>Medical Schools Boost Pain Management Education

In light of opioid epidemic, more schools focus on thoughtful prescribing

<乌鸦传媒>Is SAMHSA to Blame for a Broken Mental Health System?

Two members of Congress differ on how to fix a failing system

鈥�

13